Latest news
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_RespiriNTM-1.png
217
230
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2024-10-24 14:18:522024-10-24 14:18:5222/10/24 – BioVersys Joins RespiriNTM to Accelerate Development of the Broad-Spectrum Drug Candidates Against NTM Pulmonary Diseases
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_COMBINE.png
217
229
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2024-10-01 11:51:162024-10-01 11:51:1625/09/24 – The COMBINE Project Coordinator, Anders Karlén is Pharmacist of the Year 2024
https://amr-accelerator.eu/wp-content/uploads/2024/09/AMR-Accelerator_logos_preview-e1727427290812.jpg
768
1027
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2024-09-18 14:45:432024-10-24 13:27:03The AMR Accelerator calls to action: European capacity for antibiotic R&D requires long-term funding
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_ERA4TB.png
217
230
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2024-09-02 16:31:532024-09-02 18:12:2830/08/24 – ERA4TB to host workshop on TB Drug Development at The Union Conference 2024
https://amr-accelerator.eu/wp-content/uploads/2021/10/unite4tb-4.png
217
230
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2024-09-02 16:28:032024-09-02 16:28:0322/08/24 – UNITE4TB webinar: Management of adverse events in TB care
https://amr-accelerator.eu/wp-content/uploads/2022/02/primavera-1.png
217
230
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2024-08-15 09:58:332024-08-15 09:58:3313/08/24 – PrIMAVeRa project publishes on contact network dynamics to prevent pathogen transmission in hospitalsInterviews
https://amr-accelerator.eu/wp-content/uploads/2024/11/PRIMAVERA_ECRI-banner.png
250
800
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2024-11-26 18:01:222024-12-13 11:59:03Nasreen Hassoun-Kheir: A Doctor’s Mission to Stop Superbugs
https://amr-accelerator.eu/wp-content/uploads/2024/11/PRIMAVERA_ECRI-banner.png
250
800
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2024-11-21 14:41:582024-12-13 11:58:40Quentin J. Leclerc: Targeting Supercontactors for Safer Long-Term Care
https://amr-accelerator.eu/wp-content/uploads/2023/11/Respiris_interview.jpg
250
800
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2023-11-30 11:24:412024-12-13 12:01:05Meindert Lamers: RespiriTB & RespiriNTM ProjectsFrom the partners
https://amr-accelerator.eu/wp-content/uploads/2022/01/Partner_PrIMAVeRa_0000_ares.jpg
500
500
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-07-26 14:06:272023-07-28 14:06:3726/07/22 – OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
https://amr-accelerator.eu/wp-content/uploads/2022/07/Evotec.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-07-06 14:09:282023-07-28 14:53:2106/07/22 – Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
https://amr-accelerator.eu/wp-content/uploads/2022/04/NICE.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-04-12 13:56:112023-07-28 14:54:0512/04/22 – NICE reaches important milestone in the UK’s efforts to tackle antimicrobial resistance
https://amr-accelerator.eu/wp-content/uploads/2022/03/Uni-Dundee.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-03-04 14:00:462023-07-28 14:54:4224/03/22 – Post-Covid TB warning as DDU receives $5 million award
https://amr-accelerator.eu/wp-content/uploads/2019/04/LogoSantPau.png
756
756
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-02-01 14:04:192023-07-28 14:04:3401/02/22 – ERA4TB welcomes CIM – Sant Pau (IIB Sant Pau) as New Partner
https://amr-accelerator.eu/wp-content/uploads/2023/07/Uni-Oxford-UCL.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-11-02 13:50:102023-07-28 13:50:2102/11/21 – Antibiotic Research UK awards grants to fund research worth £200,000
ERA4TB Newsletter – July 2021
AMR Accelerator Newsletter – May 2021
ERA4TB Newsletter – May 2021
RespiriNTM & -TB Newsletter – April 2021